HealthNotableConfirmed
5.7
FDA approves new pancreatic cancer therapy demonstrating significant survival extension
N1 SerbiaLO·US·1 day ago
HealthSingle-sourceMediumDeveloping
5.2
Alnylam Pharmaceuticals faces critical clinical data presentation at ESC Congress
Alnylam Pharmaceuticals is set to present pivotal data regarding its heart medication at the European Society of Cardiology Congress in Munich. The outcome of these presentations is expected to significantly impact the company's market valuation and the clinical outlook for its cardiovascular pipeline.
Score Breakdown
Mosaic Score5.2
Confidence0.9
Significance0.5
Source credibility0.2
Related signals
8 foundHealthNotableSingle-sourceDeveloping
5.2
AstraZeneca heart disease trial failure raises efficacy concerns for silencer drug class
STAT NewsLO·GB·2 days ago
HealthSingle-sourceDeveloping
2.1
Cytokinetics reports positive trial results for potential second drug approval
STAT NewsLO·US·1 day ago
HealthSingle-sourceDeveloping
2.1
Novartis anti-inflammatory drug candidate enters clinical evaluation for cardiovascular outcomes
STAT NewsLO·CH·about 20 hours ago
HealthNotableConfirmedDeveloping
6.9
Merck reports positive late-stage trial results for personalized mRNA melanoma vaccine
La República·US·3 days ago
JusticeNotableConfirmedDeveloping
6.8
Polish authorities report surge in illegal online pharmaceutical distribution
RzeczpospolitaLO·PL·about 21 hours ago
TradeNotableCorroboratingDeveloping
6.6
European vitamin manufacturing faces existential threat from Chinese market dominance
SRFLO·CN · DE·2 days ago
JusticeNotableConfirmed
5.9
Walmart reaches settlement with U.S. DOJ over opioid prescription dispensing allegations
Valor Econômico·US·1 day ago